文献速递外周动脉疾病

创面护理优先策略在WIfI 1-2期CLTI中提供更优的无截肢生存

Wound care-first strategies provide superior amputation-free survival in patients with chronic limb-threatening ischemia Wound, Ischemia, and foot Infection clinical stages 1 and 2.
PubMed 文献 · J Vasc Surg · 2025-07-17

这项10年回顾性两中心研究分析了512例WIfI 1-2期慢性肢体威胁性缺血患者,比较保守优先与早期血运重建策略。结果显示晚期血运重建组无截肢生存最长,早期血运重建未改善无截肢生存或创面愈合,提示选择性分期方法安全有效。

要点

  • WIfI 1-2期CLTI患者中,早期血运重建未改善无截肢生存或创面愈合。
  • 晚期血运重建组无截肢生存最长,中位3677天。
  • 保肢率三组无显著差异,总体生存率晚期组最高。

核心结论

  • 在WIfI临床1-2期患者中,早期血运重建与保守管理(伴或不伴延迟血运重建)相比,未改善无截肢生存或创面愈合。
  • 这些发现提示,选择性分期方法在适当选择的低至中危CLTI患者中可能安全有效。

研究设计与样本

  • 10年回顾性两中心分析,纳入512例WIfI 1-2期CLTI患者(573条肢体),中位年龄65岁,中位随访852天。
  • 患者分为仅保守治疗、晚期血运重建和早期血运重建(就诊30天内干预)三组。

主要发现

  • 无截肢生存晚期血运重建组最长(中位3677天),早期组1756天,仅保守组1513天(P < .001)。
  • 保肢率保守组88%、早期组89%、晚期组91%,无显著差异(P = .83)。
  • 总体生存率保守组54.2%、早期组71.9%、晚期组76.4%(P = .048)。
  • 多变量分析中,仅保守治疗(HR 0.41,95%CI 0.25-0.66)和WIfI 2期(HR 0.69,95%CI 0.48-0.99)为保护因素;年龄增加(HR 1.02,P = .004)、充血性心力衰竭(HR 1.73,P < .001)和旁路闭塞(HR 1.74,P = .025)预测大截肢/死亡。

临床怎么用

  • 对于WIfI 1-2期CLTI患者,可考虑先尝试保守管理(创面护理和减压),而非立即血运重建。
  • 血运重建决策应结合趾压等缺血严重程度和共享决策,选择性采用分期策略。

局限性

  • 回顾性两中心设计可能存在选择偏倚。
  • 样本限于WIfI 1-2期患者,结论不能外推至更严重缺血人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal timing of revascularization in patients with mild-to-moderate chronic limb-threatening ischemia (CLTI) remains unclear. We aimed to evaluate long-term outcomes associated with conservative-first vs early revascularization strategies in patients with Wound, Ischemia, and foot Infection (WIfI) stage 1-2 CLTI. METHODS: A 10-year, retrospective two-center analysis of patients with WIfI stage 1-2 CLTI was conducted. At both centers, the standard practice is to revascularize patients with toe pressure <30 mm Hg, whereas those with less severe ischemia are typically offered an initial trial of conservative management (wound care and offloading). However, through shared decision-making, some patients with toe pressure >30 mm Hg may still opt for-and be offered-immediate revascularization. Patients were grouped into conservative care only, late revascularization, and early revascularization, defined as intervention <30 days from presentation. Outcomes were wound healing, major limb amputation, amputation-free survival (AFS), and mortality. RESULTS: During the study period, 1404 patients were treated at two limb preservation centers, of whom 512 (36.5%) with WIfI stage 1 or 2 limbs were analyzed (573 limbs; median age 65 years, interquartile range: 57-74 years; 60.7% male; median follow-up 852 days, interquartile range: 346-1415 days). AFS was longest in the late revascularization group (median 3677 days), followed by early revascularization (1756 days), and shortest in the conservative care only group (1513 days) (P < .001). Limb salvage was achieved in 88% of conservative, 89% of early, and 91% of late revascularization patients, with no significant differences (P = .83). Overall survival was 54.2% in the conservative group, 71.9% in the early revascularization group, and 76.4% in the late revascularization group (P = .048). On multivariable analysis, conservative care only (hazard ratio [HR]: 0.41, 95% confidence interval: 0.25-0.66) and WIfI stage 2 (HR: 0.69, 95% confidence interval: 0.48-0.99) were protective, whereas increasing age (HR: 1.02, P = .004), congestive heart failure (HR: 1.73, P < .001), and bypass occlusion (HR: 1.74, P = .025) predicted major amputation/death. In patients with ischemic wounds, survival and AFS remained highest in the late revascularization group, with no significant differences in wound healing or major amputation. CONCLUSIONS: In patients with WIfI clinical stages 1 and 2, early revascularization was not associated with improved AFS or wound healing compared with conservative management with or without delayed revascularization. These findings suggest that a selective, staged approach may be safe and effective in appropriately selected low- to moderate-risk CLTI patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Koksoy C, Torres-Ruiz I, Browder SE, et al. Wound care-first strategies provide superior amputation-free survival in patients with chronic limb-threatening ischemia Wound, Ischemia, and foot Infection clinical stages 1 and 2. J Vasc Surg. 2025. PMID: 40683393. doi:10.1016/j.jvs.2025.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。